Page 4 - Technology Commercialization News Today

Purdue University researchers are creating and testing patent-pending poly (lactic-co-glycolic acid), or PLGA, nanoparticles modified with adenosine triphosphate, or ATP, to improve immunotherapy against malignant tumors.

A noninvasive, portable tactile imaging sensor that can aid doctors when they feel an abnormality while doing physical exams on patients by detecting the size and shape of a lesion or tumor and potentially screen for breast cancer.Gene-editing technology for the treatment of patients with HIV and other viral infections such as JCV.A minimally invasive metal detector that can

WEST LAFAYETTE, Ind. — At the “Crossroads of America,” Purdue University engineers and the Indiana Department of Transportation (INDOT) are working to make it possible for electric vehicles ranging from

Bulls and cows can survive an illness called bovine respiratory disease, but it can be fatal to calves, killing about 8 million of them every year in the U.S.

The trademarked Ozark Mango, the seventh nectarine introduced by the Arkansas Fruit Breeding Program, is a yellow-fleshed and standard-acid-level nectarine tailored for growers in the U.S. southeast or mid-south.

The AUC-Granted collaboration includes Morehouse College, Morehouse School of Medicine, and Clark Atlanta University...

Jordan will work with researchers to bring a greater number of new technologies, innovations and scientific breakthroughs to the clinic, enabling breakthroughs

Published annually since 2013, the report ranks the top 100 universities holding U.S. utility patents, which protect the way an invention is used and works, in the 2023 calendar year.

<p>The move, part of the institution’s <a href="https://www.stjude.org/media-resources/special-announcements/st-jude-strategic-plan-2022-27.html">2022-2027 Strategic Plan</a>, represents a new commitment to help St. Jude researchers patent, license and commercialize their work, whether through collaboration with industry partners, launching startup companies, or expanding licensing efforts to established companies.</p>

Jordan will work with researchers to bring a greater number of new technologies, innovations and scientific breakthroughs to the clinic, enabling breakthroughs